BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25481771)

  • 1. The structure function of the death domain of human IRAK-M.
    Du J; Nicolaes GA; Kruijswijk D; Versloot M; van der Poll T; van 't Veer C
    Cell Commun Signal; 2014 Dec; 12():77. PubMed ID: 25481771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial lipoprotein-induced tolerance is reversed by overexpression of IRAK-1.
    Li CH; Liu J; An M; Redmond HP; Wang JH
    Immunol Cell Biol; 2012 Mar; 90(3):314-20. PubMed ID: 21537341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-beta-activated kinase 1 activation, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated factor 6, and IkappaB kinase gamma and increases A20 expression.
    Xiong Y; Qiu F; Piao W; Song C; Wahl LM; Medvedev AE
    J Biol Chem; 2011 Mar; 286(10):7905-7916. PubMed ID: 21220427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of IRAK-1 activation by its C-terminal domain.
    Nguyen T; De Nardo D; Masendycz P; Hamilton JA; Scholz GM
    Cell Signal; 2009 May; 21(5):719-26. PubMed ID: 19166926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model.
    van 't Veer C; van den Pangaart PS; van Zoelen MA; de Kruif M; Birjmohun RS; Stroes ES; de Vos AF; van der Poll T
    J Immunol; 2007 Nov; 179(10):7110-20. PubMed ID: 17982103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal structure of IRAK-1 to induce degradation of TRAF6.
    Watanabe S; Zenke K; Sugiura Y; Muroi M
    Immunobiology; 2022 Sep; 227(5):152256. PubMed ID: 35926385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procyanidin dimer B2-mediated IRAK-M induction negatively regulates TLR4 signaling in macrophages.
    Sung NY; Yang MS; Song DS; Kim JK; Park JH; Song BS; Park SH; Lee JW; Park HJ; Kim JH; Byun EB; Byun EH
    Biochem Biophys Res Commun; 2013 Aug; 438(1):122-8. PubMed ID: 23872113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of IL-1 Receptor-Associated Kinase-4 Leads to Defective Th1 Cell Responses and Renders Mice Susceptible to Mycobacterial Infection.
    Marinho FV; Fahel JS; Scanga CA; Gomes MT; Guimarães G; Carvalho GR; Morales SV; Báfica A; Oliveira SC
    J Immunol; 2016 Sep; 197(5):1852-63. PubMed ID: 27439514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals.
    Williams KL; Lich JD; Duncan JA; Reed W; Rallabhandi P; Moore C; Kurtz S; Coffield VM; Accavitti-Loper MA; Su L; Vogel SN; Braunstein M; Ting JP
    J Biol Chem; 2005 Dec; 280(48):39914-24. PubMed ID: 16203735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.
    Pantazi I; Al-Qahtani AA; Alhamlan FS; Alothaid H; Matou-Nasri S; Sourvinos G; Vergadi E; Tsatsanis C
    Front Immunol; 2021; 12():683800. PubMed ID: 34248968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of the interleukin-1-receptor-associated kinase (IRAK-1) in interleukin-1 beta-stimulated nuclear factor kappa B (NF-kappa B) pathway activation: IRAK-1 associates with the NF-kappa B essential modulator (NEMO) upon receptor stimulation.
    Cooke EL; Uings IJ; Xia CL; Woo P; Ray KP
    Biochem J; 2001 Oct; 359(Pt 2):403-10. PubMed ID: 11583588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel splice variant of mouse interleukin-1-receptor-associated kinase-1 (IRAK-1) activates nuclear factor-kappaB (NF-kappaB) and c-Jun N-terminal kinase (JNK).
    Yanagisawa K; Tago K; Hayakawa M; Ohki M; Iwahana H; Tominaga S
    Biochem J; 2003 Feb; 370(Pt 1):159-66. PubMed ID: 12418963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient membrane recruitment of IRAK-1 in response to LPS and IL-1beta requires TNF R1.
    Lockett A; Goebl MG; Harrington MA
    Am J Physiol Cell Physiol; 2008 Aug; 295(2):C313-23. PubMed ID: 18562480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A20 inhibits toll-like receptor 2- and 4-mediated interleukin-8 synthesis in airway epithelial cells.
    Gon Y; Asai Y; Hashimoto S; Mizumura K; Jibiki I; Machino T; Ra C; Horie T
    Am J Respir Cell Mol Biol; 2004 Sep; 31(3):330-6. PubMed ID: 15142865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-β1 re-programs TLR4 signaling in L. donovani infection: enhancement of SHP-1 and ubiquitin-editing enzyme A20.
    Das S; Pandey K; Kumar A; Sardar AH; Purkait B; Kumar M; Kumar S; Ravidas VN; Roy S; Singh D; Das P
    Immunol Cell Biol; 2012 Jul; 90(6):640-54. PubMed ID: 21968712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Threonine 66 in the death domain of IRAK-1 is critical for interaction with signaling molecules but is not a target site for autophosphorylation.
    Neumann D; Kollewe C; Pich A; Cao P; Resch K; Martin MU
    J Leukoc Biol; 2008 Sep; 84(3):807-13. PubMed ID: 18524972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
    Heyninck K; De Valck D; Vanden Berghe W; Van Criekinge W; Contreras R; Fiers W; Haegeman G; Beyaert R
    J Cell Biol; 1999 Jun; 145(7):1471-82. PubMed ID: 10385526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation.
    Conze DB; Wu CJ; Thomas JA; Landstrom A; Ashwell JD
    Mol Cell Biol; 2008 May; 28(10):3538-47. PubMed ID: 18347055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IRAK-M death domain: a tale of three surfaces.
    Gürkan B; Poelman H; Pereverzeva L; Kruijswijk D; de Vos AF; Groenen AG; Nollet EE; Wichapong K; Lutgens E; van der Poll T; Du J; Wiersinga WJ; Nicolaes GAF; van 't Veer C
    Front Mol Biosci; 2023; 10():1265455. PubMed ID: 38268724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variant IL-1 receptor-associated kinase-1 mediates increased NF-kappa B activity.
    Liu G; Tsuruta Y; Gao Z; Park YJ; Abraham E
    J Immunol; 2007 Sep; 179(6):4125-34. PubMed ID: 17785851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.